A business in context

EYPT research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-10-17 · 0001193125-26-424755 · Items 2.02,2.05,8.01,9.01

  2. 8-K · Current report

    Report date 2026-10-19 · 0001193125-26-424644 · Items 8.01,9.01

  3. 8-K · Current report

    Report date 2026-09-10 · 0001193125-26-387197 · Items 8.01,9.01

  4. 4 · Ownership change

    Report date 2026-08-20 · 0001429932-26-000010

  5. 4 · Ownership change

    Report date 2026-08-18 · 0001530968-26-000004

  6. 8-K · Current report

    Report date 2026-08-17 · 0001193125-26-353308 · Items 8.01,9.01

  7. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-335037

  8. 8-K · Current report

    Report date 2026-08-05 · 0001193125-26-333821 · Items 2.02,9.01

  9. 8-K · Current report

    Report date 2026-07-30 · 0001193125-26-324866 · Items 8.01,9.01

  10. 8-K · Current report

    Report date 2026-07-13 · 0001193125-26-307792 · Items 1.01,9.01

  11. 4 · Ownership change

    Report date 2026-07-10 · 0001630864-26-000010

  12. 4 · Ownership change

    Report date 2026-06-30 · 0002013623-26-000012

  13. 8-K · Current report

    Report date 2026-06-18 · 0001193125-26-276688 · Items 5.02,5.07,9.01

  14. 4 · Ownership change

    Report date 2026-05-25 · 0001429932-26-000008

  15. 8-K · Current report

    Report date 2026-05-14 · 0001193125-26-222750 · Items 8.01,9.01

  16. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-211870

  17. 8-K · Current report

    Report date 2026-05-06 · 0001193125-26-207537 · Items 2.02,9.01

  18. DEF 14A · Proxy statement

    Report date 2026-06-18 · 0001193125-26-182035

  19. 4 · Ownership change

    Report date 2026-04-17 · 0002013623-26-000010

  20. 8-K · Current report

    Report date 2026-04-13 · 0001193125-26-152852 · Items 8.01,9.01

  21. 4 · Ownership change

    Report date 2026-03-23 · 0001630864-26-000008

  22. 8-K · Current report

    Report date 2026-03-20 · 0001193125-26-117745 · Items 7.01

  23. 4 · Ownership change

    Report date 2026-03-16 · 0001630864-26-000006

  24. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-093917

  25. 8-K · Current report

    Report date 2026-03-04 · 0001193125-26-089856 · Items 2.02,9.01

  26. 8-K · Current report

    Report date 2026-02-26 · 0001193125-26-084154 · Items 8.01,9.01

  27. 8-K · Current report

    Report date 2026-01-07 · 0001193125-26-005418 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-12-08 · 0001193125-25-310731 · Items 5.03,9.01

  29. 8-K · Current report

    Report date 2025-11-19 · 0001193125-25-286961 · Items 8.01,9.01

  30. 8-K · Current report

    Report date 2025-11-06 · 0001193125-25-270145 · Items 8.01,9.01

  31. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-269471

  32. 8-K · Current report

    Report date 2025-11-05 · 0001193125-25-265706 · Items 2.02,9.01

  33. 8-K · Current report

    Report date 2025-10-14 · 0001193125-25-241639 · Items 1.01,8.01,9.01

  34. 8-K · Current report

    Report date 2025-10-14 · 0001193125-25-239008 · Items 2.02,8.01,9.01

  35. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001193125-25-175418

  36. 8-K · Current report

    Report date 2025-08-06 · 0000950170-25-103527 · Items 2.02,9.01

  37. 8-K/A · Current report

    Report date 2025-07-29 · 0000950170-25-099413 · Items 8.01,9.01

  38. 8-K · Current report

    Report date 2025-07-29 · 0000950170-25-099383 · Items 8.01,9.01

  39. 8-K · Current report

    Report date 2025-06-18 · 0000950170-25-088169 · Items 5.02,5.07,9.01

  40. 8-K · Current report

    Report date 2025-05-27 · 0000950170-25-077373 · Items 8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 1 transaction rows1PSale: 2 transaction rows2SGrant / award: 0 transaction rows0AExercise / conversion: 6 transaction rows6MTax / exercise payment: 1 transaction rows1FGift: 2 transaction rows2G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

14 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-20
2026-08-24
Elston GeorgeJ · Other (see filing)
Disposed
Common Stock5000.00.0
2026-08-20
2026-08-24
Elston GeorgeJ · Other (see filing)
Acquired
Common Stock5000.00.0
2026-08-20
2026-08-24
Elston GeorgeG · Gift
Disposed
Common Stock64953.00.0
2026-08-20
2026-08-24
Elston GeorgeG · Gift
Acquired
Common Stock64953.00.0
2026-08-18
2026-08-18
Zaderej Karen L.P · Purchase
Acquired
Common Stock10600.04.93
2026-07-10
2026-07-14
Duker Jay S.M · Exercise / conversion
Acquired
Common Stock16667.00.0
2026-07-10
2026-07-14
Duker Jay S.F · Tax / exercise payment
Disposed
Common Stock8059.014.72
2026-07-10
2026-07-14
Duker Jay S.M · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
16667.00.0
2026-06-30
2026-07-02
Ribeiro RamiroM · Exercise / conversion
Acquired
Common Stock2437.08.26
2026-06-30
2026-07-02
Ribeiro RamiroS · Sale
Disposed
Common Stock2438.015.02
2026-06-30
2026-07-02
Ribeiro RamiroS · Sale
Disposed
Common Stock2437.015.0
2026-06-30
2026-07-02
Ribeiro RamiroM · Exercise / conversion
Acquired
Common Stock2438.08.26
2026-06-30
2026-07-02
Ribeiro RamiroM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
2437.00.0
2026-06-30
2026-07-02
Ribeiro RamiroM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
2438.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001314102EyePoint, Inc.
pSivida

Showing 1 of 1 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300QE1RU34T50MR69
GLEIF legal name
EYEPOINT, INC.
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2025-12-19T16:18:01Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • EyePoint Pharmaceuticals · alias · wikidata
  • pSivida Corp. · alias · wikidata
  • pSivida · subsidiary · wikidata
  • EyePoint Pharmaceuticals (United Kingdom) · subsidiary · wikidata
  • EyePoint Pharmaceuticals, Inc. · former SEC name · 2018-04-02 to 2025-12-08
  • pSivida Corp. · former SEC name · 2008-06-19 to 2018-03-30
  • pSivida LTD · former SEC name · 2005-01-20 to 2008-06-18
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$43.27M$46.48M
2023-12-31$46.02M$50.88M
2022-12-31$41.40M$47.66M
2021-12-31$36.94M$45.92M
2020-12-31$34.44M$44.83M
2019-12-31$20.36M$26.84M
2018-12-31$4.57M$6.13M

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗